Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation

Adjuvants are key components in vaccines, they help in reducing the required antigen dose but also modulate the phenotype of the induced immune response. We previously showed that GPI-0100, a saponin-derived adjuvant, enhances antigen-specific mucosal and systemic antibody responses to influenza sub...

Full description

Bibliographic Details
Main Authors: Harshad P. Patil, José Herrera Rodriguez, Jacqueline de Vries-Idema, Tjarko Meijerhof, Henderik W. Frijlink, Wouter L. J. Hinrichs, Anke Huckriede
Format: Article
Language:English
Published: MDPI AG 2017-07-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/5/3/19
id doaj-b6b0f2c48095449f8125a519889b7a19
record_format Article
spelling doaj-b6b0f2c48095449f8125a519889b7a192020-11-24T21:08:45ZengMDPI AGVaccines2076-393X2017-07-01531910.3390/vaccines5030019vaccines5030019Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell ProliferationHarshad P. Patil0José Herrera Rodriguez1Jacqueline de Vries-Idema2Tjarko Meijerhof3Henderik W. Frijlink4Wouter L. J. Hinrichs5Anke Huckriede6Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The NetherlandsDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The NetherlandsDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The NetherlandsDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The NetherlandsDepartment of Pharmaceutical Technology and Biopharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The NetherlandsDepartment of Pharmaceutical Technology and Biopharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The NetherlandsDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The NetherlandsAdjuvants are key components in vaccines, they help in reducing the required antigen dose but also modulate the phenotype of the induced immune response. We previously showed that GPI-0100, a saponin-derived adjuvant, enhances antigen-specific mucosal and systemic antibody responses to influenza subunit and whole inactivated influenza virus (WIV) vaccine administered via the pulmonary route. However, the impact of the GPI-0100 dose on immune stimulation and the immune mechanisms stimulated by GPI-0100 along with antigen are poorly understood. Therefore, in this study we immunized C57BL/6 mice via the pulmonary route with vaccine consisting of WIV combined with increasing amounts of GPI-0100, formulated as a dry powder. Adjuvantation of WIV enhanced influenza-specific mucosal and systemic immune responses, with intermediate doses of 5 and 7.5 μg GPI-0100 being most effective. The predominant antibody subtype induced by GPI-0100-adjuvanted vaccine was IgG1. Compared to non-adjuvanted vaccine, GPI-0100-adjuvanted WIV vaccine gave rise to higher numbers of antigen-specific IgA- but not IgG-producing B cells in the lungs along with better mucosal and systemic memory B cell responses. The GPI-0100 dose was negatively correlated with the number of influenza-specific IFNγ- and IL17-producing T cells and positively correlated with the number of IL4-producing T cells observed after immunization and challenge. Overall, our results show that adjuvantation of pulmonary-delivered WIV with GPI-0100 mostly affects B cell responses and effectively induces B cell memory.https://www.mdpi.com/2076-393X/5/3/19influenzapulmonary immunizationadjuvantimmune mechanisms
collection DOAJ
language English
format Article
sources DOAJ
author Harshad P. Patil
José Herrera Rodriguez
Jacqueline de Vries-Idema
Tjarko Meijerhof
Henderik W. Frijlink
Wouter L. J. Hinrichs
Anke Huckriede
spellingShingle Harshad P. Patil
José Herrera Rodriguez
Jacqueline de Vries-Idema
Tjarko Meijerhof
Henderik W. Frijlink
Wouter L. J. Hinrichs
Anke Huckriede
Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation
Vaccines
influenza
pulmonary immunization
adjuvant
immune mechanisms
author_facet Harshad P. Patil
José Herrera Rodriguez
Jacqueline de Vries-Idema
Tjarko Meijerhof
Henderik W. Frijlink
Wouter L. J. Hinrichs
Anke Huckriede
author_sort Harshad P. Patil
title Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation
title_short Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation
title_full Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation
title_fullStr Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation
title_full_unstemmed Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation
title_sort adjuvantation of pulmonary-administered influenza vaccine with gpi-0100 primarily stimulates antibody production and memory b cell proliferation
publisher MDPI AG
series Vaccines
issn 2076-393X
publishDate 2017-07-01
description Adjuvants are key components in vaccines, they help in reducing the required antigen dose but also modulate the phenotype of the induced immune response. We previously showed that GPI-0100, a saponin-derived adjuvant, enhances antigen-specific mucosal and systemic antibody responses to influenza subunit and whole inactivated influenza virus (WIV) vaccine administered via the pulmonary route. However, the impact of the GPI-0100 dose on immune stimulation and the immune mechanisms stimulated by GPI-0100 along with antigen are poorly understood. Therefore, in this study we immunized C57BL/6 mice via the pulmonary route with vaccine consisting of WIV combined with increasing amounts of GPI-0100, formulated as a dry powder. Adjuvantation of WIV enhanced influenza-specific mucosal and systemic immune responses, with intermediate doses of 5 and 7.5 μg GPI-0100 being most effective. The predominant antibody subtype induced by GPI-0100-adjuvanted vaccine was IgG1. Compared to non-adjuvanted vaccine, GPI-0100-adjuvanted WIV vaccine gave rise to higher numbers of antigen-specific IgA- but not IgG-producing B cells in the lungs along with better mucosal and systemic memory B cell responses. The GPI-0100 dose was negatively correlated with the number of influenza-specific IFNγ- and IL17-producing T cells and positively correlated with the number of IL4-producing T cells observed after immunization and challenge. Overall, our results show that adjuvantation of pulmonary-delivered WIV with GPI-0100 mostly affects B cell responses and effectively induces B cell memory.
topic influenza
pulmonary immunization
adjuvant
immune mechanisms
url https://www.mdpi.com/2076-393X/5/3/19
work_keys_str_mv AT harshadppatil adjuvantationofpulmonaryadministeredinfluenzavaccinewithgpi0100primarilystimulatesantibodyproductionandmemorybcellproliferation
AT joseherrerarodriguez adjuvantationofpulmonaryadministeredinfluenzavaccinewithgpi0100primarilystimulatesantibodyproductionandmemorybcellproliferation
AT jacquelinedevriesidema adjuvantationofpulmonaryadministeredinfluenzavaccinewithgpi0100primarilystimulatesantibodyproductionandmemorybcellproliferation
AT tjarkomeijerhof adjuvantationofpulmonaryadministeredinfluenzavaccinewithgpi0100primarilystimulatesantibodyproductionandmemorybcellproliferation
AT henderikwfrijlink adjuvantationofpulmonaryadministeredinfluenzavaccinewithgpi0100primarilystimulatesantibodyproductionandmemorybcellproliferation
AT wouterljhinrichs adjuvantationofpulmonaryadministeredinfluenzavaccinewithgpi0100primarilystimulatesantibodyproductionandmemorybcellproliferation
AT ankehuckriede adjuvantationofpulmonaryadministeredinfluenzavaccinewithgpi0100primarilystimulatesantibodyproductionandmemorybcellproliferation
_version_ 1716759548530786304